AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15974216 — intervention group
Group type: COMPARATOR
Intervention: Colgate Winterfresh Gel (CWG)
Number of subjects: 0
Study 12709609 — intervention group
Group type: EXPERIMENTAL
Intervention: Early laparoscopic cholecystectomy (ELC)
Number of subjects: 169
Study 12709609 — intervention group
Group type: COMPARATOR
Intervention: Delayed laparoscopic cholecystectomy (DLC)
Number of subjects: 169
Study 10478139 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel flow cytometric approach for TdT expression detection
Number of subjects: 68
Study 10478139 — intervention group
Group type: COMPARATOR
Intervention: Parallel immunoperoxidase staining and microscopic evaluation
Number of subjects: 68
Study 8609242 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (50 mg, single oral dose)
Number of subjects: 8
Study 8609242 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 1960828 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy plus the best medical care (n = 91)
Number of subjects: 189
Study 1960828 — intervention group
Group type: COMPARATOR
Intervention: Best medical care alone (n = 98)
Number of subjects: 189
Study 7274266 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinidine arabogalactane-sulfate (QAGS)
Number of subjects: 207
Study 7274266 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 207
Study 31010126 — intervention group
Group type: EXPERIMENTAL
Intervention: TMPRSS6 SNP rs855791
Number of subjects: 121
Study 31010126 — intervention group
Group type: EXPERIMENTAL
Intervention: TMPRSS6 SNP rs4820268
Number of subjects: 121
Study 29098257 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral implantation
Number of subjects: 94
Study 29098257 — intervention group
Group type: COMPARATOR
Intervention: Conventional restoration
Number of subjects: 94
Study 26163028 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic VSL#3 (10 billion cfu) for 30 days
Number of subjects: 1340
Study 26163028 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1340
Study 23602881 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle strength exercises (SE)
Number of subjects: 451
Study 23602881 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercises (AE)
Number of subjects: 451
Study 20632222 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based decision aid (Decision-Aid Group, n = 60)
Number of subjects: 121
Study 19589139 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy
Number of subjects: 318
Study 19589139 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 318
Study 19589139 — intervention group
Group type: COMPARATOR
Intervention: Acute stress patients
Number of subjects: 318
Study 17361532 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine (TCM) recipes formulated by Shen‐replenishing herbs or acupuncture
Number of subjects: 0
Study 17361532 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy of Shen‐replenishing recipe and acupuncture with hormone or ovulation promoting drugs of Western medicine
Number of subjects: 0
Study 12919759 — intervention group
Group type: EXPERIMENTAL
Intervention: Needleless connectors
Number of subjects: 77
Study 12919759 — intervention group
Group type: COMPARATOR
Intervention: Standard caps
Number of subjects: 77
Study 12919759 — intervention group
Group type: EXPERIMENTAL
Intervention: Isopropyl alcohol
Number of subjects: 77
Study 12919759 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine/alcohol
Number of subjects: 77
Study 12919759 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone-iodine
Number of subjects: 77
Study 11314640 — intervention group
Group type: EXPERIMENTAL
Intervention: Training plus accountability (experimental group I)
Number of subjects: 0
Study 11314640 — intervention group
Group type: EXPERIMENTAL
Intervention: Training without accountability (experimental group II)
Number of subjects: 0
Study 11314640 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 0
Study 9396637 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-molecular weight heparins (LMWHs)
Number of subjects: 0
Study 9396637 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct thrombin inhibitors
Number of subjects: 0
Study 8418711 — intervention group
Group type: EXPERIMENTAL
Intervention: Preinduction Acute Hemodilution (AH)
Number of subjects: 40
Study 8418711 — intervention group
Group type: EXPERIMENTAL
Intervention: Postinduction Acute Hemodilution (AH)
Number of subjects: 40
Study 8418711 — intervention group
Group type: COMPARATOR
Intervention: Control (Homologous Blood Transfusion)
Number of subjects: 40
Study 2948987 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 60
Study 2948987 — intervention group
Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 60
Study 30113915 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow Accentuated Eccentric Loading (AEL)
Number of subjects: 14
Study 30113915 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast Accentuated Eccentric Loading (AEL)
Number of subjects: 14
Study 30113915 — intervention group
Group type: COMPARATOR
Intervention: Fast Traditional Resistance Training (TRT)
Number of subjects: 14
Study 26807536 — intervention group
Group type: EXPERIMENTAL
Intervention: BPI (Brief Pain Inventory)
Number of subjects: 250
Study 26807536 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG (3-item PEG scale)
Number of subjects: 250
Study 26807536 — intervention group
Group type: EXPERIMENTAL
Intervention: SF-36 Bodily Pain
Number of subjects: 250
Study 26807536 — intervention group
Group type: EXPERIMENTAL
Intervention: PROMIS Pain Interference short forms
Number of subjects: 250
Study 26807536 — intervention group
Group type: COMPARATOR
Intervention: BPI, PEG, SF-36 Bodily Pain, PROMIS Pain Interference
Number of subjects: 250
Study 23904206 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation
Number of subjects: 73
Study 23904206 — intervention group
Group type: COMPARATOR
Intervention: Placebo-electrical stimulation
Number of subjects: 73
Study 23904206 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation (Control)
Number of subjects: 73
Study 22378728 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (specific intervention details not provided)
Number of subjects: 230
Study 20467009 — intervention group
Group type: EXPERIMENTAL
Intervention: Tertile III caloric intake (>64.6%)
Number of subjects: 523
Study 20467009 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing caloric intake
Number of subjects: 523
Study 20467009 — intervention group
Group type: COMPARATOR
Intervention: Tertile I caloric intake (<33.4%)
Number of subjects: 523
Study 18158630 — intervention group
Group type: EXPERIMENTAL
Intervention: Early feeding (clear fluids and solid food within 8 h of surgery)
Number of subjects: 179
Study 18158630 — intervention group
Group type: COMPARATOR
Intervention: Traditionally fed (clear fluids 8-12 h after surgery)
Number of subjects: 179
Study 15962873 — intervention group
Group type: EXPERIMENTAL
Intervention: Easyhaler
Number of subjects: 326
Study 15962873 — intervention group
Group type: EXPERIMENTAL
Intervention: Diskus
Number of subjects: 326
Study 15962873 — intervention group
Group type: EXPERIMENTAL
Intervention: Turbuhaler
Number of subjects: 326
Study 12667600 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyphenol-rich juice A (236 mg polyphenols, cyanidin glycosides)
Number of subjects: 0
Study 12667600 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyphenol-rich juice B (226 mg polyphenols, epigallocatechin gallate)
Number of subjects: 0
Study 12667600 — intervention group
Group type: COMPARATOR
Intervention: Control (no juice)
Number of subjects: 0
Study 11194788 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung volume reduction surgery (LVRS)
Number of subjects: 0
Study 11194788 — intervention group
Group type: COMPARATOR
Intervention: Intensive medical management including pulmonary rehabilitation
Number of subjects: 0
Study 11194788 — intervention group
Group type: COMPARATOR
Intervention: Surgical techniques (bilateral by MS or VATS)
Number of subjects: 0
Study 11194788 — intervention group
Group type: COMPARATOR
Intervention: Selection criteria for optimal response
Number of subjects: 0
Study 11194788 — intervention group
Group type: COMPARATOR
Intervention: Criteria to determine prohibitive surgical risk
Number of subjects: 0
Study 11194788 — intervention group
Group type: COMPARATOR
Intervention: Long-term cost effectiveness
Number of subjects: 0
Study 8795441 — intervention group
Group type: EXPERIMENTAL
Intervention: gamma‐L‐glutamyl‐L‐3,4‐dihydroxyphenylalanine (gludopa)
Number of subjects: 8
Study 8795441 — intervention group
Group type: EXPERIMENTAL
Intervention: gamma‐L‐glutamyl‐5‐hydroxy‐L‐tryptophan
Number of subjects: 8
Study 8795441 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous infusion of gludopa and gamma‐L‐glutamyl‐5‐hydroxy‐L‐tryptophan
Number of subjects: 8
Study 1531218 — intervention group
Group type: EXPERIMENTAL
Intervention: etanidazole combined with radiotherapy (ETA)
Number of subjects: 374
Study 1531218 — intervention group
Group type: COMPARATOR
Intervention: radiotherapy alone (RT)
Number of subjects: 374
Study 6372934 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecystokinin (CCK) infusion (1 Ivy Dog Unit/kg over 5 min)
Number of subjects: 41
Study 6372934 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (placebo) infusion
Number of subjects: 41
Study 6372934 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecystectomy
Number of subjects: 41
Study 6372934 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeat CCK infusion postoperatively
Number of subjects: 41
Study 29699509 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term fasting (STF) during chemotherapy
Number of subjects: 34
Study 29699509 — intervention group
Group type: COMPARATOR
Intervention: Normocaloric diet (non-fasted) during chemotherapy
Number of subjects: 34
Study 29699509 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term fasting (STF)
Number of subjects: 34
Study 29699509 — intervention group
Group type: COMPARATOR
Intervention: Normocaloric diet (non-fasted)
Number of subjects: 34
Study 29471772 — intervention group
Group type: EXPERIMENTAL
Intervention: Psycho-education group
Number of subjects: 64
Study 29471772 — intervention group
Group type: COMPARATOR
Intervention: Control group (standardized educational materials)
Number of subjects: 64
Study 24875026 — intervention group
Group type: EXPERIMENTAL
Intervention: Patellar eversion
Number of subjects: 120
Study 24875026 — intervention group
Group type: COMPARATOR
Intervention: Patellar lateral retraction
Number of subjects: 120
Study 22031510 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training at 60-80% of maximal oxygen consumption (VO2max) for 10 weeks, three 1-hour sessions per week.
Number of subjects: 28
Study 22031510 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training
Number of subjects: 28
Study 20706626 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine (CQ)
Number of subjects: 307
Study 20706626 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 307
Study 18519174 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate (RIS), 35 mg once weekly
Number of subjects: 87
Study 18519174 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 87
Study 15960638 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg.kg(‐1) oral midazolam
Number of subjects: 100
Study 15960638 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 mg.kg(‐1) oral midazolam with 2.5 mg.kg(‐1) oral ketamine
Number of subjects: 100
Study 15960638 — intervention group
Group type: COMPARATOR
Intervention: Control group (midazolam alone)
Number of subjects: 100
Study 15960638 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (midazolam alone and midazolam with ketamine)
Number of subjects: 100
Study 12438486 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular change of ventricular catheter every five days
Number of subjects: 103
Study 12438486 — intervention group
Group type: COMPARATOR
Intervention: No change unless clinically indicated
Number of subjects: 103
Study 10622653 — intervention group
Group type: COMPARATOR
Intervention: BUP 0.5% with no EPI
Number of subjects: 40
Study 10622653 — intervention group
Group type: EXPERIMENTAL
Intervention: BUP 0.5% with EPI 1:300,000
Number of subjects: 40
Study 10622653 — intervention group
Group type: COMPARATOR
Intervention: BUP 0.25% with no EPI
Number of subjects: 40
Study 10622653 — intervention group
Group type: EXPERIMENTAL
Intervention: BUP 0.25% with EPI 1:300,000
Number of subjects: 40
Study 7485479 — intervention group
Group type: EXPERIMENTAL
Intervention: L-[3,4-3H]glutamine infusion
Number of subjects: 6
Study 7485479 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 6
Study 7485479 — intervention group
Group type: COMPARATOR
Intervention: Natural L-glutamine infusion
Number of subjects: 6
Study 1826739 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron 0.15 mg/kg IV every 4 hours for three doses
Number of subjects: 307
Study 1826739 — intervention group
Group type: COMPARATOR
Intervention: Metoclopramide 2 mg/kg IV every 2 hours for three doses, then every 3 hours for three additional doses
Number of subjects: 307
Study 6789798 — intervention group
Group type: EXPERIMENTAL
Intervention: Hanks' transport media
Number of subjects: 200
Study 6789798 — intervention group
Group type: EXPERIMENTAL
Intervention: Stuart's transport media
Number of subjects: 200
Study 6789798 — intervention group
Group type: EXPERIMENTAL
Intervention: Leibovitz‐Emory (LEM) transport media
Number of subjects: 200
Study 31593559 — intervention group
Group type: EXPERIMENTAL
Intervention: 25g of phenols-rich extra virgin olive oil (p-EVOO)
Number of subjects: 22
Study 26210962 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine (2%) with adrenaline (0.01%)
Number of subjects: 50
Study 26210962 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine (2%) without adrenaline
Number of subjects: 50
Study 25616192 — intervention group
Group type: EXPERIMENTAL
Intervention: Feeding Dynamic Intervention (FDI)
Number of subjects: 0
Study 25616192 — intervention group
Group type: COMPARATOR
Intervention: Wait-list Control Group (WLC)
Number of subjects: 0
Study 23912950 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate plus vitamin D3 5,600 IU (ALN/D)
Number of subjects: 391
Study 23912950 — intervention group
Group type: COMPARATOR
Intervention: Standard care (SC) with alendronate (SC/ALN)
Number of subjects: 391
Study 22887722 — intervention group
Group type: EXPERIMENTAL
Intervention: Women with heart failure with preserved ejection fraction
Number of subjects: 4128
Study 22887722 — intervention group
Group type: COMPARATOR
Intervention: Men with heart failure with preserved ejection fraction
Number of subjects: 4128
Study 19406691 — intervention group
Group type: EXPERIMENTAL
Intervention: Body-weight supported treadmill training (BWSTT)
Number of subjects: 7
Study 19406691 — intervention group
Group type: COMPARATOR
Intervention: Head-up tilt training (HUTT)
Number of subjects: 7
Study 17425814 — intervention group
Group type: EXPERIMENTAL
Intervention: Entropy group (propofol induction based on entropy reading)
Number of subjects: 72
Study 17425814 — intervention group
Group type: COMPARATOR
Intervention: Control group (recommended induction dose of propofol)
Number of subjects: 72
Study 15611507 — intervention group
Group type: EXPERIMENTAL
Intervention: myeloablative radiochemotherapy followed by ASCT
Number of subjects: 440
Study 15611507 — intervention group
Group type: COMPARATOR
Intervention: interferon alfa (IFN-alpha) maintenance
Number of subjects: 440
Study 11227969 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin (100 IU/kg, intravenously) administered immediately after introduction of the femoral venous sheaths (group I)
Number of subjects: 30
Study 11227969 — intervention group
Group type: COMPARATOR
Intervention: Heparin administered after the initial electrophysiological study (groups II and III)
Number of subjects: 30
Study 11227969 — intervention group
Group type: COMPARATOR
Intervention: Saline irrigation of all femoral sheaths (group II)
Number of subjects: 30
Study 11134095 — intervention group
Group type: EXPERIMENTAL
Intervention: High calcium intake (47.4 mmol/day)
Number of subjects: 10
Study 11134095 — intervention group
Group type: COMPARATOR
Intervention: Low calcium intake (21.2 mmol/day)
Number of subjects: 10
Study 9345833 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin therapy
Number of subjects: 50
Study 8186380 — intervention group
Group type: COMPARATOR
Intervention: Hyoscine N-butyl bromide (20 mg)
Number of subjects: 46
Study 8186380 — intervention group
Group type: EXPERIMENTAL
Intervention: Propinoxate (5 mg) plus diazepam
Number of subjects: 46
Study 2951570 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin phosphate (1% solution)
Number of subjects: 34
Study 2951570 — intervention group
Group type: COMPARATOR
Intervention: Tetracycline (solution)
Number of subjects: 34
Study 30145122 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative visitation by surgical technologist (intervention group)
Number of subjects: 70
Study 30145122 — intervention group
Group type: COMPARATOR
Intervention: Routine preoperative care by nurses (control group)
Number of subjects: 70
Study 29370257 — intervention group
Group type: EXPERIMENTAL
Intervention: Ear endoscopy
Number of subjects: 32
Study 29370257 — intervention group
Group type: COMPARATOR
Intervention: Ear microscopy
Number of subjects: 32
Study 27732647 — intervention group
Group type: EXPERIMENTAL
Intervention: Grooming
Number of subjects: 16
Study 27732647 — intervention group
Group type: EXPERIMENTAL
Intervention: Food competition
Number of subjects: 16
Study 27732647 — intervention group
Group type: EXPERIMENTAL
Intervention: Food anticipation
Number of subjects: 16
Study 27732647 — intervention group
Group type: EXPERIMENTAL
Intervention: Waving a plastic bag
Number of subjects: 16
Study 27732647 — intervention group
Group type: COMPARATOR
Intervention: Control phases
Number of subjects: 16
Study 24256028 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 306
Study 24256028 — intervention group
Group type: COMPARATOR
Intervention: Control (routine care only)
Number of subjects: 306
Study 21941363 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-down posture
Number of subjects: 30
Study 21941363 — intervention group
Group type: COMPARATOR
Intervention: No posture
Number of subjects: 30
Study 20234000 — intervention group
Group type: EXPERIMENTAL
Intervention: Web administration of the Youth Risk Behavior Survey (YRBS)
Number of subjects: 5227
Study 20234000 — intervention group
Group type: COMPARATOR
Intervention: Paper-and-pencil administration of the Youth Risk Behavior Survey (YRBS)
Number of subjects: 5227
Study 18567678 — intervention group
Group type: EXPERIMENTAL
Intervention: mct/lct-propofol with lidocaine 10 mg/ml
Number of subjects: 160
Study 18567678 — intervention group
Group type: COMPARATOR
Intervention: lct-propofol with saline
Number of subjects: 160
Study 18567678 — intervention group
Group type: EXPERIMENTAL
Intervention: lct-propofol with lidocaine 10 mg/ml
Number of subjects: 160
Study 18567678 — intervention group
Group type: COMPARATOR
Intervention: mct/lct-propofol with saline
Number of subjects: 160
Study 16422890 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone patch
Number of subjects: 28
Study 16422890 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone gel
Number of subjects: 28
Study 16422890 — intervention group
Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 28
Study 12424331 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation (including one can of V-8 juice daily) for 2 weeks
Number of subjects: 23
Study 12424331 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 10076483 — intervention group
Group type: EXPERIMENTAL
Intervention: Mass media-led smoking cessation campaign (including television shows, a television clinic, a quit line, local group programs, and a comprehensive publicity campaign)
Number of subjects: 1338
Study 10076483 — intervention group
Group type: EXPERIMENTAL
Intervention: Mass media-led smoking cessation campaign
Number of subjects: 1338
Study 10076483 — intervention group
Group type: COMPARATOR
Intervention: Control group (nonpretested baseline smokers)
Number of subjects: 1338
Study 7719761 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (3 mg/kg in saline)
Number of subjects: 6
Study 7719761 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 6
Study 2035860 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric bupivacaine (0.25% mixed with 10% dextrose)
Number of subjects: 45
Study 2035860 — intervention group
Group type: EXPERIMENTAL
Intervention: Isobaric bupivacaine (0.25% mixed with 0.9% NaCl)
Number of subjects: 45
Study 2035860 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypobaric bupivacaine (0.25% mixed with distilled water)
Number of subjects: 45
Study 2035860 — intervention group
Group type: COMPARATOR
Intervention: Hyperbaric bupivacaine (0.25%)
Number of subjects: 45
Study 2035860 — intervention group
Group type: COMPARATOR
Intervention: Isobaric bupivacaine (0.25%)
Number of subjects: 45
Study 2035860 — intervention group
Group type: COMPARATOR
Intervention: Hypobaric bupivacaine (0.25%)
Number of subjects: 45
Study 31145226 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous (IV) ketorolac
Number of subjects: 224
Study 31418043 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary rehabilitation 5 times/week for 4 weeks
Number of subjects: 39
Study 31418043 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 39
Study 27763895 — intervention group
Group type: EXPERIMENTAL
Intervention: Low urine output target of 0.2 mL/kg/h
Number of subjects: 40
Study 27763895 — intervention group
Group type: COMPARATOR
Intervention: Standard urine output target of 0.5 mL/kg/h
Number of subjects: 40
Study 26472590 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (AG)
Number of subjects: 66
Study 26472590 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EG)
Number of subjects: 66
Study 24565620 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer support group meetings and mp3 peer-recorded asthma messages
Number of subjects: 68
Study 24565620 — intervention group
Group type: COMPARATOR
Intervention: Attention control group (ATG) with weekly meetings with a research assistant and mp3 physician-recorded asthma messages
Number of subjects: 68
Study 21482925 — intervention group
Group type: EXPERIMENTAL
Intervention: Natalizumab
Number of subjects: 49